- Home
- KMDA vs MYD Comparison
KMDA vs MYD Comparison
Compare KMDA & MYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- MYD
- Stock Information
- Founded
- KMDA 1990
- MYD 1991
- Country
- KMDA Israel
- MYD United States
- Employees
- KMDA N/A
- MYD N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- MYD Investment Bankers/Brokers/Service
- Sector
- KMDA Health Care
- MYD Finance
- Exchange
- KMDA Nasdaq
- MYD Nasdaq
- Market Cap
- KMDA 398.5M
- MYD 460.1M
- IPO Year
- KMDA N/A
- MYD N/A
- Fundamental
- Price
- KMDA $6.62
- MYD $10.57
- Analyst Decision
- KMDA Strong Buy
- MYD
- Analyst Count
- KMDA 2
- MYD 0
- Target Price
- KMDA $13.00
- MYD N/A
- AVG Volume (30 Days)
- KMDA 70.7K
- MYD 253.1K
- Earning Date
- KMDA 11-10-2025
- MYD 01-01-0001
- Dividend Yield
- KMDA 3.00%
- MYD 4.55%
- EPS Growth
- KMDA 27.97
- MYD N/A
- EPS
- KMDA 0.32
- MYD N/A
- Revenue
- KMDA $169,517,000.00
- MYD N/A
- Revenue This Year
- KMDA $14.49
- MYD N/A
- Revenue Next Year
- KMDA $10.12
- MYD N/A
- P/E Ratio
- KMDA $20.13
- MYD N/A
- Revenue Growth
- KMDA 9.67
- MYD N/A
- 52 Week Low
- KMDA $5.54
- MYD $8.76
- 52 Week High
- KMDA $9.16
- MYD $11.30
- Technical
- Relative Strength Index (RSI)
- KMDA 42.74
- MYD 49.37
- Support Level
- KMDA $6.66
- MYD $10.50
- Resistance Level
- KMDA $6.93
- MYD $10.67
- Average True Range (ATR)
- KMDA 0.17
- MYD 0.08
- MACD
- KMDA -0.02
- MYD -0.01
- Stochastic Oscillator
- KMDA 10.71
- MYD 34.21
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About MYD Blackrock MuniYield Fund Inc.
Blackrock Muniyield Fund Inc is a non-diversified, closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.